Olanzapine and mirtazapine for multiple palliation.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000627:therapeutic use*; D003863:Depression / Q000188:drug therapy / Q000209:etiology; D004359:Drug Therapy, Combination; D006801:Humans; D008803:Mianserin / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D000078785:Mirtazapine; D009325:Nausea / Q000188:drug therapy / Q000209:etiology; D009369:Neoplasms / Q000150:complications*; D000077152:Olanzapine; D010166:Palliative Care; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*
D000317:Adrenergic alpha-Antagonists; D001569:Benzodiazepines; D008803:Mianserin; D000078785:Mirtazapine; D000077152:Olanzapine; D017367:Selective Serotonin Reuptake Inhibitors